MicroRNAs as Modulators of the Immune Response in T-Cell Acute Lymphoblastic Leukemia

被引:7
|
作者
Del Gaizo, Martina [1 ]
Sergio, Ilaria [2 ]
Lazzari, Sara [1 ]
Cialfi, Samantha [1 ]
Pelullo, Maria [3 ]
Screpanti, Isabella [1 ]
Felli, Maria Pia [2 ]
机构
[1] Sapienza Univ Rome, Dept Mol Med, I-00161 Rome, Italy
[2] Sapienza Univ Rome, Dept Expt Med, I-00161 Rome, Italy
[3] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, I-00161 Rome, Italy
关键词
microRNA; Notch; Natural Killer cells; T and regulatory T cells; MDSC; Acute lymphoblastic leukaemia; SUPPRESSOR-CELLS; TUMOR-SUPPRESSOR; MOLECULAR-MECHANISMS; NK CELLS; NOTCH; EXPRESSION; ACTIVATION; INFLAMMATION; REVEALS; EVASION;
D O I
10.3390/ijms23020829
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute lymphoblastic leukaemia (ALL) is an aggressive haematological tumour driven by the malignant transformation and expansion of B-cell (B-ALL) or T-cell (T-ALL) progenitors. The evolution of T-ALL pathogenesis encompasses different master developmental pathways, including the main role played by Notch in cell fate choices during tissue differentiation. Recently, a growing body of evidence has highlighted epigenetic changes, particularly the altered expression of microRNAs (miRNAs), as a critical molecular mechanism to sustain T-ALL. The immune response is emerging as key factor in the complex multistep process of cancer but the role of miRNAs in anti-leukaemia response remains elusive. In this review we analyse the available literature on miRNAs as tuners of the immune response in T-ALL, focusing on their role in Natural Killer, T, T-regulatory and Myeloid-derived suppressor cells. A better understanding of this molecular crosstalk may provide the basis for the development of potential immunotherapeutic strategies in the leukemia field.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] MicroRNA expression and activity in T-cell acute lymphoblastic leukemia
    Ye, Fang
    ONCOTARGET, 2018, 9 (04): : 5445 - 5458
  • [2] MYC in T-cell acute lymphoblastic leukemia: functional implications and targeted strategies
    Li, Qilong
    Pan, Sa
    Xie, Ting
    Liu, Hudan
    BLOOD SCIENCE, 2021, 3 (03): : 65 - 70
  • [3] T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness
    Bardelli, Valentina
    Arniani, Silvia
    Pierini, Valentina
    Di Giacomo, Danika
    Pierini, Tiziana
    Gorello, Paolo
    Mecucci, Cristina
    La Starza, Roberta
    GENES, 2021, 12 (08)
  • [4] T-cell acute lymphoblastic leukemia
    Chiaretti, Sabina
    Foa, Robin
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (02): : 160 - 162
  • [5] Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia
    Lulla, Premal D.
    Mamonkin, Maksim
    Brenner, Malcolm K.
    CANCER JOURNAL, 2019, 25 (03) : 199 - 207
  • [6] Notch Inhibitors and BH3 Mimetics in T-Cell Acute Lymphoblastic Leukemia
    Sergio, Ilaria
    Varricchio, Claudia
    Squillante, Federica
    Aeo, Noemi Martina Cantale
    Campese, Antonio Francesco
    Felli, Maria Pia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [7] MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia
    Gebarowska, Katarzyna
    Mroczek, Anna
    Kowalczyk, Jerzy R.
    Lejman, Monika
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [8] microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia
    Correia, Nadia C.
    Melao, Alice
    Povoa, Vanda
    Sarmento, Leonor
    Gomez de Cedron, Marta
    Malumbres, Marcos
    Enguita, Francisco J.
    Barata, Joao T.
    ONCOTARGET, 2016, 7 (07) : 8268 - 8281
  • [9] Leukemia-initiating Cells in T-Cell Acute Lymphoblastic Leukemia
    Tan, Shi Hao
    Bertulfo, Fatima Carla
    Sanda, Takaomi
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [10] Pediatric T-Cell Acute Lymphoblastic Leukemia
    Karrman, Kristina
    Johansson, Bertil
    GENES CHROMOSOMES & CANCER, 2017, 56 (02) : 89 - 116